INTESA SANPAOLO (I07186) 시세

Is your life so miserable that you spend incessant amounts of time on this board poo--pooing this company? You are either a disgruntled ex-employee, a rival business investor or just bored.

IGNORED.

Red you must live pretty close to The Players near Jacksonville - did you ever watch a PGA tourney in person?

~~COMPX 3/13/2025~~~~~~~

Previous Close

17648.45 +212.35

17799 SSKILLZ1

Hopefully it doesn't stop with the USDA.

That doesn't really bother me, assuming that these things come to fruition in the near future and we get some more details.

I'm also quite curious what Novavax covid vaccine does to bone marrow memory cells. We now know that mRNA shots do not produce these cells, which is a normal function of vaccination. I expect Novavax to come out with a publication confirming their vaccine does induce these cells, similar to other pr

Nice try.

IGNORE.

It does feel like a slow drip with a bang saved at the tail end.

As of what date and did this come from the company?

miss bolshie does that literally every time. It's called disinformational lying.

Fact is you have zero idea wwtf you are talking about just ask MAYO CLINIC AND JHU ....

Stay home ELMER FUD .....

By the way how are those human clinical trials going for the

GLUE STICK

Kiwi, I think a sequential comparison vs Q3 24 may be more apt where they did $30 million in US product revenue and to increase that to 44 and change ain’t bad, albeit they had to fine up margin to drive volume. Another encouraging point was they are already selling in China to private hospitals and

For "Right to Try", you forgot patient has to have the means to pay for treatment too, as insurance typically won't cover experimental treatment.

As far as "progress" in India, what "progress"? If the five initial patients in India were properly dosed (treated tumors dead) so that

Out 50% at $1.39, (37,500 shares).

Holding remaining 50%, (37,500 shares), for tomorrow's announcement.

Thanks for reminding me why everyone quit iHub! 

It's incredible really with all sorts of market beating products and patents s . No orders it's stayed at a market cap 20 million or less at 20 ,cents , for 6 or 5 years and for a market target that's supposed be worth 1 billion by 2027 ,manipulation !!!!!!!

.0002 tomorrow? Probably around the corner.

My Y00ESC# shows MISSING now on my
Schwab account. Not sure why.
Just don’t trust this entire process honestly.
I have called multiple times to confirm that
I am due to get paid. I’m on the list and they received my confirmation etc.
Hopefully everything is ok.

Biotech IPOs that include warrants are pretty unusual and probably best avoided. ADTX is a case in point—the share price is down 99.8% from its 2020 IPO. The company is implementing a 1:250 reverse split, LOL:

https://www.businesswire.com/news/home/20250312389566/en

There should still be time left before 10k.

.008’s tommorow??

TRVI—(+38%)—reports phase-2 data in chronic cough

Surprised it jumped this much given that the Ph2s are layups. The real risk is in the Ph3s for a variety of reasons (eg people with chronic cough tend to improve a lot over longer periods of time, and, somewhat perversely, more so wit

IS son, IS.